AtriCure, Inc. (ATRC)
49.27
+0.29
(+0.59%)
USD |
NASDAQ |
Aug 24, 16:00
49.27
0.00 (0.00%)
After-Hours: 20:00
AtriCure Net Income (Quarterly) : 8.955M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.955M |
| March 31, 2026 | 0.108M |
| December 31, 2025 | 1.756M |
| September 30, 2025 | -0.267M |
| June 30, 2025 | -6.19M |
| March 31, 2025 | -6.747M |
| December 31, 2024 | -15.57M |
| September 30, 2024 | -7.853M |
| June 30, 2024 | -8.008M |
| March 31, 2024 | -13.27M |
| December 31, 2023 | -9.789M |
| September 30, 2023 | -9.055M |
| June 30, 2023 | -5.118M |
| March 31, 2023 | -6.476M |
| December 31, 2022 | -4.17M |
| September 30, 2022 | -12.27M |
| June 30, 2022 | -14.84M |
| March 31, 2022 | -15.18M |
| December 31, 2021 | -13.74M |
| September 30, 2021 | 97.11M |
| June 30, 2021 | -16.25M |
| March 31, 2021 | -16.92M |
| December 31, 2020 | -18.56M |
| September 30, 2020 | -4.949M |
| June 30, 2020 | -8.236M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.41M |
| December 31, 2019 | -16.10M |
| September 30, 2019 | -9.362M |
| June 30, 2019 | -4.101M |
| March 31, 2019 | -5.635M |
| December 31, 2018 | -3.43M |
| September 30, 2018 | -7.235M |
| June 30, 2018 | -0.338M |
| March 31, 2018 | -10.13M |
| December 31, 2017 | -2.58M |
| September 30, 2017 | -7.246M |
| June 30, 2017 | -6.883M |
| March 31, 2017 | -10.18M |
| December 31, 2016 | -8.625M |
| September 30, 2016 | -6.783M |
| June 30, 2016 | -8.206M |
| March 31, 2016 | -9.724M |
| December 31, 2015 | -10.91M |
| September 30, 2015 | -6.141M |
| June 30, 2015 | -4.891M |
| March 31, 2015 | -5.266M |
| December 31, 2014 | -5.344M |
| September 30, 2014 | -0.466M |
| June 30, 2014 | -2.692M |
| March 31, 2014 | -7.709M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp. | 905.00M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 153.60M |
| Total Expenses (Quarterly) | 144.65M |
| EPS Diluted (Quarterly) | 0.1832 |
| Enterprise Value | 2.398B |
| Gross Profit Margin (Quarterly) | 76.75% |
| Profit Margin (Quarterly) | 5.83% |
| Earnings Yield | 0.44% |
| Operating Earnings Yield | 0.58% |
| Normalized Earnings Yield | 0.4690 |